Issue 52, 2023

Hydrolyzable emulsions as a dual release platform for hydrophobic drugs and DNA

Abstract

Several challenges need to be overcome when applying nucleic acids as therapeutic agents. We developed a new way to control the onset of the release of cholesterol-conjugated oligonucleotides with a simple, versatile, and cheap platform. Moreover, we combine the platform into a dual-release system that can release a hydrophobic drug with zero-order kinetics, followed by a rapid release of cholesterol-conjugated DNA.

Graphical abstract: Hydrolyzable emulsions as a dual release platform for hydrophobic drugs and DNA

Supplementary files

Article information

Article type
Communication
Submitted
24 Feb 2023
Accepted
15 May 2023
First published
23 May 2023

Chem. Commun., 2023,59, 8099-8102

Hydrolyzable emulsions as a dual release platform for hydrophobic drugs and DNA

L. Tebcharani, N. Akter, D. Fan, O. Lieleg, J. M. Gibbs and J. Boekhoven, Chem. Commun., 2023, 59, 8099 DOI: 10.1039/D3CC00888F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements